News
NIH is seeking feedback from stakeholders to assist in defining specific, measurable indicators and incentives that reflect the collaborative, rigorous, and mission-driven nature of modern biomedical science. NIH is particularly interested in comments that include specific examples of measurable
Cell Lines for the Study of Neurodegenerative Disorders and their Treatments Available for Licensing
Gaucher disease is a rare and heterogenous disorder caused by inherited Glucocerebrosidase (GBA1) genetic mutations. The National Human Genome Research Institute (NHGRI) has six cell lines available for licensing for the study of GBA1 mutations. These cell lines can be used to study the defects in
It’s almost the new year – get ahead on your planning with the Federal Laboratory Consortium (FLC)’s free 2023 planner! This planner features images submitted from a variety of federal labs, showcasing a new technology each month. The FLC planner is a great way to track all of your important dates
Hear from Dr. Stephen Adler, lead inventor of a new micro-dose calibrator, at an upcoming technology webinar hosted by the National Cancer Institute (NCI). The discovery is an improved radiation measurement instrument which provides a new level of sensitivity, accuracy, and range for measurement of